Related Experiment Video
Updated: Dec 29, 2025
Application of an Amplitude-integrated EEG Monitor Cerebral Function Monitor to Neonates
Published on: September 6, 2017
Prognostic value of amplitude-integrated EEG in neonates with high risk of neurological sequelae
Xiao Yuan1, Wenqing Kang2, Juan Song1
1Henan Key Laboratory of Child Brain Injury, Third Affiliated Hospital and Institute of Neuroscience, Zhengzhou University, Zhengzhou, 450052, China.
Insights
Amplitude-integrated electroencephalography (aEEG) effectively predicts neurological outcomes in high-risk newborns. This method aids in monitoring neonates at risk for adverse neurological development.
Area of Science:
- Neonatal Neurology
- Neurophysiology
- Pediatric Neurology
Background:
- Neonatal encephalopathy and brain injury pose significant risks for long-term neurological sequelae.
- Early identification and monitoring of at-risk neonates are crucial for timely intervention.
- Amplitude-integrated electroencephalography (aEEG) is a bedside tool used in neonatal intensive care.
Purpose of the Study:
- To evaluate the diagnostic efficacy of aEEG in predicting neurological outcomes.
- To assess the prognostic value of aEEG in term and near-term neonates at high risk for neurological sequelae.
- To determine if aEEG findings correlate with 12-month neurological development assessments.
Main Methods:
- A cohort of 250 neonates (≥35 weeks gestation) at high risk for brain injury or with neonatal encephalopathy were included.
- aEEG monitoring was performed within 6 hours of clinical assessment.
- Infants were followed for 12 months to assess neurological development.
Main Results:
- Severely abnormal aEEG patterns were found in 84 infants, with 62 ultimately diagnosed with neurological disability at 12 months.
- Severely abnormal aEEG demonstrated high predictive accuracy for adverse neurological outcomes (Sensitivity: 70.2%, Specificity: 87.1%, PPV: 75.6%, NPV: 83.7%).
- A total of 209 infants completed the 12-month follow-up, with 62 exhibiting neurological disabilities.
Conclusions:
- aEEG is a valuable and effective tool for predicting adverse neurological outcomes in high-risk neonates.
- The prognostic capability of aEEG supports its use in monitoring neonates susceptible to neurological complications.
- Early aEEG assessment can guide clinical management and prognostication in neonatal neurology.
Objective:
To determine the efficacy and the prognostic value of amplitude-integrated electroencephalography (aEEG) in term and near-term neonates with high risk of neurological sequelae.
Methods:
Infants of ≥35 weeks of gestation diagnosed with neonatal encephalopathy or with high risk of brain injury were included. All eligible infants underwent aEEG within 6 h after clinical assessment. The infants were followed up 12 months to evaluate neurological development.
Results:
A total of 250 infants were eligible, of which 85 had normal aEEG, 81 had mildly abnormal aEEG, and 84 had severely abnormal aEEG. Of these infants, 168 were diagnosed with different neonatal encephalopathies, 27 with congenital or metabolic diseases, and 55 with high risk of brain injury. In all, 22 infants died, 19 were lost to follow-up, and 209 completed the follow-up at 12 months, of which 62 were diagnosed with a neurological disability. Statistical analysis showed that severely abnormal aEEG predicted adverse neurological outcome with a sensitivity of 70.2%, a specificity of 87.1%, a positive predictive value of 75.6%, and a negative predictive value of 83.7%.
Interpretation:
aEEG can predict adverse outcomes in high-risk neonates and is a useful method for monitoring neonates with high risk of adverse neurological outcomes.
